Follicle Pharma
PrivateLast Round
Seed
Jan 1, 2021
Total Funding Raised
$5M
Company Overview
Follicle Pharma operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in January 2021.
Follicle Pharma is a biotechnology company that develops topical targeted delivery systems for the treatment of follicular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Follicle Pharma Comparables
Compare Follicle Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Soterios Pharma | 79% | |
| Dermaliq Therapeutics, Inc. | 78% | |
| Cosmo Pharmaceuticals N.V. | 74% |
For institutional investors. Book with your work email.
Follicle Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Follicle Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maruho Israel Innovation Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 603% MoM to 1.4K.
- Mar 2, 2026
Monthly visitors grew 442% MoM, from 412 to 2.2K.
For institutional investors. Book with your work email.
Follicle Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Follicle Pharma's valuation, stock price, and market status.
Is Follicle Pharma a public or private company?
Follicle Pharma is a private company.
What is the current stock price of Follicle Pharma?
Follicle Pharma is a private company, so its shares have no public market price. Caplight tracks Follicle Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Follicle Pharma worth (valuation)?
Valuation information for Follicle Pharma is not publicly available.
Can I buy Follicle Pharma stock?
Follicle Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Follicle Pharma's last funding round?
Follicle Pharma's most recent funding round was Seed on January 1, 2021.
Who are the main investors in Follicle Pharma?
Key investors in Follicle Pharma include Maruho Israel Innovation Fund.
Will Follicle Pharma IPO soon?
No public IPO plans have been announced for Follicle Pharma.
How can I track Follicle Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Follicle Pharma's shares on secondary markets.